Dynamic development of glucocorticoid resistance during autoimmune neuroinflammation

Journal of Clinical Endocrinology and Metabolism

Volumn 97, Issue 8, 2012, Pages

  Gold, Stefan M ^a,b   Sasidhar, Manda V ^b   Lagishetty, Venu ^b   Spence, Rory D ^b   Umeda, Elizabeth ^b   Ziehn, Marina O ^b   Krieger, Thorsten ^a   Schulz, Karl Heinz ^a   Heesen, Christoph ^a   Hewison, Martin ^b   Voskuhl, Rhonda R ^b  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR ALPHA; MESSENGER RNA;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN SPECIFICITY; APOPTOSIS; ARTICLE; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG SENSITIVITY; FEMALE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IMMUNOREGULATION; IN VIVO STUDY; LYMPHOCYTE PROLIFERATION; LYMPHOCYTIC INFILTRATION; MALE; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PREGNANCY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PUERPERIUM; RECEPTOR DOWN REGULATION; RECURRENCE RISK; REGULATORY MECHANISM; SYMPTOM; T LYMPHOCYTE; TRANSLATIONAL RESEARCH;

ANIMALS; APOPTOSIS; AUTOANTIGENS; CROSS-SECTIONAL STUDIES; DRUG RESISTANCE; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; GLUCOCORTICOIDS; GLYCOPROTEINS; HUMANS; MALE; MICE; MICE, INBRED C57BL; MULTIPLE SCLEROSIS; PEPTIDE FRAGMENTS; RECEPTORS, GLUCOCORTICOID; T-LYMPHOCYTES;

ANIMALIA; MUS;

EID: 84864818552     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2012-1294     Document Type: Article

References (35)

1. Barnes PJ, Adcock IM 2009 Glucocorticoid resistance in inflammatory diseases. Lancet 373:1905-1917
2. Webster JI, Tonelli L, Sternberg EM 2002 Neuroendocrine regulation of immunity. Annu Rev Immunol 20:125-163 (Pubitemid 34295785)
3. Mason D, MacPhee I, Antoni F 1990 The role of the neuroendocrine system in determining genetic susceptibility to experimental allergic encephalomyelitis in the rat. Immunology 70:1-5 (Pubitemid 20148055)
4. MacPhee IA, Antoni FA, Mason DW 1989 Spontaneous recovery of rats from experimental allergic encephalomyelitis is dependent on regulation of the immune system by endogenous adrenal corticosteroids. J Exp Med 169:431-445 (Pubitemid 19050641)
5. van den Brandt J, Lühder F, McPherson KG, de Graaf KL, Tischner D, Wiehr S, Herrmann T, Weissert R, Gold R, Reichardt HM 2007 Enhanced glucocorticoid receptor signaling in T cells impacts thymocyte apoptosis and adaptive immune responses. Am J Pathol 170:1041-1053 (Pubitemid 47339371)
6. Wüst S, van den Brandt J, Tischner D, Kleiman A, Tuckermann JP, Gold R, Lühder F, Reichardt HM 2008 Peripheral T cells are the therapeutic targets of glucocorticoids in experimental autoimmune encephalomyelitis. J Immunol 180:8434-8443
7. van Winsen LM, Muris DF, Polman CH, Dijkstra CD, van den Berg TK, Uitdehaag BM 2005 Sensitivity to glucocorticoids is decreased in relapsing remitting multiple sclerosis. J Clin Endocrinol Metab 90:734-740 (Pubitemid 40279188)
8. DeRijk RH, Eskandari F, Sternberg EM 2004 Corticosteroid resistance in a subpopulation of multiple sclerosis patients as measured by ex vivo dexamethasone inhibition of LPS induced IL-6 production. J Neuroimmunol 151:180-188 (Pubitemid 38624412)
9. Ysrraelit MC, Gaitán MI, Lopez AS, Correale J 2008 Impaired hypothalamic-pituitary-adrenal axis activity in patients with multiple sclerosis. Neurology 71:1948-1954
10. Matysiak M, Makosa B, Walczak A, Selmaj K 2008 Patients with multiple sclerosis resisted to glucocorticoid therapy: abnormal expression of heat-shock protein 90 in glucocorticoid receptor complex. Mult Scler 14:919-926
11. van Winsen LM, Polman CH, Dijkstra CD, Tilders FJ, Uitdehaag BM 2010 Suppressive effect of glucocorticoids on TNF-α production is associated with their clinical effect in multiple sclerosis. Mult Scler 16:500-502
12. Sliwinska-Stanczyk P, Pazdur J, Ziolkowska M, Jaworski J, Kaminska-Tchorzewska E, Lacki JK 2007 The effect of methylprednisolone on proliferation of PBMCs obtained from steroid-sensitive and steroid-resistant rheumatoid arthritis patients. Scand J Rheumatol 36:167-171 (Pubitemid 47174544)
13. DeRijk RH, Schaaf M, de Kloet ER 2002 Glucocorticoid receptor variants: clinical implications. J Steroid Biochem Mol Biol 81:103-122 (Pubitemid 34879139)
14. van Winsen LL, Hooper-van Veen T, van Rossum EF, Polman CH, van den Berg TK, Koper JW, Uitdehaag BM 2005 The impact of glucocorticoid receptor gene polymorphisms on glucocorticoid sensitivity is outweighted in patients with multiple sclerosis. J Neuroimmunol 167:150-156 (Pubitemid 41242297)
15. Webster JC, Oakley RH, Jewell CM, Cidlowski JA 2001 Proinflammatory cytokines regulate human glucocorticoid receptor gene expression and lead to the accumulation of the dominant negative βisoform: a mechanism for the generation of glucocorticoid resistance. Proc Natl Acad Sci USA 98:6865-6870 (Pubitemid 32538308)
16. Tsitoura DC, Rothman PB 2004 Enhancement of MEK/ERK signaling promotes glucocorticoid resistance in CD4+ T cells. J Clin Invest 113:619-627 (Pubitemid 38542511)
17. Heesen C, Schulz KH, Fielder J, Von der Mark U, Otte C, Jung R, Poettgen J, Krieger T, Gold SM 2010 Correlates of cognitive dysfunction in multiple sclerosis. Brain Behav Immun 24:1148-1155
18. Fischer A, Otte C, Krieger T, Nicholls RA, Kruger S, Ziegler KJ, Schulz KH, Heesen C, Gold SM 26 March 2012 Decreased hydrocortisone sensitivity of T cell function in multiple sclerosisassociated major depression. Psychoneuroendocrinology doi: 10.1016/j.psyneuen.2012.03.001.
19. Ishida Y, Heersche JN 1998 Glucocorticoid-induced osteoporosis: both in vivo and in vitro concentrations of glucocorticoids higher than physiological levels attenuate osteoblast differentiation. J Bone Miner Res 13:1822-1826 (Pubitemid 28535838)
20. Spence RD, Hamby ME, Umeda E, Itoh N, Du S, Wisdom AJ, Cao Y, Bondar G, Lam J, Ao Y, Sandoval F, Suriany S, Sofroniew MV, Voskuhl RR 2011 Neuroprotection mediated through estrogen receptor-αin astrocytes. Proc Natl Acad Sci USA 108:8867-8872
21. Whitacre CC, Reingold SC, O'Looney PA 1999 A gender gap in autoimmunity. Science 283:1277-1278 (Pubitemid 129507205)
22. Donia M, Mangano K, Quattrocchi C, Fagone P, Signorelli S, Magro G, Sfacteria A, Bendtzen K, Nicoletti F 2010 Specific and strainindependent effects of dexamethasone in the prevention and treatment of experimental autoimmune encephalomyelitis in rodents. Scand J Immunol 72:396-407
23. Flügel A, Odoardi F, Nosov M, Kawakami N 2007 Autoaggressive effector T cells in the course of experimental autoimmune encephalomyelitis visualized in the light of two-photon microscopy. J Neuroimmunol 191:86-97 (Pubitemid 350061003)
24. Schweingruber N, Reichardt SD, Lühder F, Reichardt HM 2012 Mechanisms of glucocorticoids in the control of neuroinflammation. J Neuroendocrinol 24:174-182
25. Confavreux C, Hutchinson M, Hours MM, Cortinovis-Tourniaire P, Moreau T 1998 Rate of pregnancy-related relapse in multiple sclerosis. Pregnancy in Multiple Sclerosis Group. N Engl J Med 339:285-291 (Pubitemid 28366416)
26. Stefferl A, Storch MK, Linington C, Stadelmann C, Lassmann H, Pohl T, Holsboer F, Tilders FJ, Reul JM 2001 Disease progression in chronic relapsing experimental allergic encephalomyelitis is associated with reduced inflammation-driven production of corticosterone. Endocrinology 142:3616-3624 (Pubitemid 32681772)
27. Stefferl A, Linington C, Holsboer F, Reul JM 1999 Susceptibility and resistance to experimental allergic encephalomyelitis: relationship with hypothalamic-pituitary-adrenocortical axis responsiveness in the rat. Endocrinology 140:4932-4938
28. Flügel A, Berkowicz T, Ritter T, Labeur M, Jenne DE, Li Z, Ellwart JW, Willem M, Lassmann H, Wekerle H 2001 Migratory activity and functional changes of green fluorescent effector cells before and during experimental autoimmune encephalomyelitis. Immunity 14:547-560 (Pubitemid 32520866)
29. Tischner D, van den Brandt J, Weishaupt A, Lühder F, Herold MJ, Reichardt HM 2009 Stable silencing of the glucocorticoid receptor in myelin-specific T effector cells by retroviral delivery of shRNA: insight into neuroinflammatory disease. Eur J Immunol 39:2361-2370
30. Mohr DC, Hart SL, Julian L, Cox D, Pelletier D 2004 Association between stressful life events and exacerbation in multiple sclerosis: a meta-analysis. BMJ 328:731
31. Artemiadis AK, Anagnostouli MC, Alexopoulos EC 2011 Stress as a risk factor for multiple sclerosis onset or relapse: a systematic review. Neuroepidemiology 36:109-120
32. Stark JL, Avitsur R, Padgett DA, Campbell KA, Beck FM, Sheridan JF 2001 Social stress induces glucocorticoid resistance in macrophages. Am J Physiol Regul Integr Comp Physiol 280:R1799-R1805
33. Quan N, Avitsur R, Stark JL, He L, Lai W, Dhabhar F, Sheridan JF 2003 Molecular mechanisms of glucocorticoid resistance in splenocytes of socially stressed male mice. J Neuroimmunol 137:51-58 (Pubitemid 36351565)
34. Miller GE, Chen E 2006 Life stress and diminished expression of genes encoding glucocorticoid receptor and β2-adrenergic receptor in children with asthma. Proc Natl Acad Sci USA 103:5496-5501
35. Chan J, Rabbitt EH, Innes BA, Bulmer JN, Stewart PM, Kilby MD, Hewison M 2007 Glucocorticoid-induced apoptosis in human decidua: a novel role for 11β-hydroxysteroid dehydrogenase in late gestation. J Endocrinol 195:7-15 (Pubitemid 350055994)